1
|
Bagheri AR, Aramesh N, Bilal M, Xiao J, Kim HW, Yan B. Carbon nanomaterials as emerging nanotherapeutic platforms to tackle the rising tide of cancer - A review. Bioorg Med Chem 2021; 51:116493. [PMID: 34781082 DOI: 10.1016/j.bmc.2021.116493] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2021] [Revised: 10/30/2021] [Accepted: 11/02/2021] [Indexed: 12/12/2022]
Abstract
Cancer has become one of the main reasons for human death in recent years. Around 18 million new cancer cases and approximately 9.6 million deaths from cancer reported in 2018, and the annual number of cancer cases will have increased to 22 million in the next two decades. These alarming facts have rekindled researchers' attention to develop and apply different approaches for cancer therapy. Unfortunately, most of the applied methods for cancer therapy not only have adverse side effects like toxicity and damage of healthy cells but also have a short lifetime. To this end, introducing innovative and effective methods for cancer therapy is vital and necessary. Among different potential materials, carbon nanomaterials can cope with the rising threats of cancer. Due to unique physicochemical properties of different carbon nanomaterials including carbon, fullerene, carbon dots, graphite, single-walled carbon nanotube and multi-walled carbon nanotubes, they exhibit possibilities to address the drawbacks for cancer therapy. Carbon nanomaterials are prodigious materials due to their ability in drug delivery or remedial of small molecules. Functionalization of carbon nanomaterials can improve the cancer therapy process and decrement the side effects. These exceptional traits make carbon nanomaterials as versatile and prevalent materials for application in cancer therapy. This article spotlights the recent findings in cancer therapy using carbon nanomaterials (2015-till now). Different types of carbon nanomaterials and their utilization in cancer therapy were highlighted. The plausible mechanisms for the action of carbon nanomaterials in cancer therapy were elucidated and the advantages and disadvantages of each material were also illustrated. Finally, the current problems and future challenges for cancer therapy based on carbon nanomaterials were discussed.
Collapse
Affiliation(s)
| | - Nahal Aramesh
- Department of Chemistry, University of Isfahan, Isfahan 81746-73441, Iran.
| | - Muhammad Bilal
- School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
| | - Jiafu Xiao
- Hunan Province Key Laboratory for Antibody-based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, PR China
| | - Hae-Won Kim
- Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116, Republic of Korea; Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Republic of Kore; Department of Biomaterials Science, College of Dentistry, Dankook University, Cheonan 31116, Republic of Korea; UCL Eastman-Korea Dental Medicine Innovation Centre, Dankook University, Cheonan 31116, Republic of Korea; Cell & Matter Institute, Dankook University, Cheonan 31116, South Korea
| | - Bing Yan
- Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou 510006, China; Institute of Environmental Research at Greater Bay Area, Ministry of Education, Guangzhou University, Guangzhou 510006, China.
| |
Collapse
|
2
|
Wang JTW, Klippstein R, Martincic M, Pach E, Feldman R, Šefl M, Michel Y, Asker D, Sosabowski JK, Kalbac M, Da Ros T, Ménard-Moyon C, Bianco A, Kyriakou I, Emfietzoglou D, Saccavini JC, Ballesteros B, Al-Jamal KT, Tobias G. Neutron Activated 153Sm Sealed in Carbon Nanocapsules for in Vivo Imaging and Tumor Radiotherapy. ACS NANO 2020; 14:129-141. [PMID: 31742990 DOI: 10.1021/acsnano.9b04898] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Radiation therapy along with chemotherapy and surgery remain the main cancer treatments. Radiotherapy can be applied to patients externally (external beam radiotherapy) or internally (brachytherapy and radioisotope therapy). Previously, nanoencapsulation of radioactive crystals within carbon nanotubes, followed by end-closing, resulted in the formation of nanocapsules that allowed ultrasensitive imaging in healthy mice. Herein we report on the preparation of nanocapsules initially sealing "cold" isotopically enriched samarium (152Sm), which can then be activated on demand to their "hot" radioactive form (153Sm) by neutron irradiation. The use of "cold" isotopes avoids the need for radioactive facilities during the preparation of the nanocapsules, reduces radiation exposure to personnel, prevents the generation of nuclear waste, and evades the time constraints imposed by the decay of radionuclides. A very high specific radioactivity is achieved by neutron irradiation (up to 11.37 GBq/mg), making the "hot" nanocapsules useful not only for in vivo imaging but also therapeutically effective against lung cancer metastases after intravenous injection. The high in vivo stability of the radioactive payload, selective toxicity to cancerous tissues, and the elegant preparation method offer a paradigm for application of nanomaterials in radiotherapy.
Collapse
Affiliation(s)
- Julie T-W Wang
- Institute of Pharmaceutical Science , King's College London , London SE1 9NH , United Kingdom
| | - Rebecca Klippstein
- Institute of Pharmaceutical Science , King's College London , London SE1 9NH , United Kingdom
| | - Markus Martincic
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC) , Campus UAB, 08193 Bellaterra, Barcelona , Spain
| | - Elzbieta Pach
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) , CSIC and the Barcelona Institute of Science and Technology , Campus UAB, 08193 Bellaterra, Barcelona , Spain
| | - Robert Feldman
- Cis Bio International Ion Beam Applications SA , Gif sur Yvette 91192 , France
| | - Martin Šefl
- Medical Physics Laboratory , University of Ioannina Medical School , Ioannina 45110 , Greece
- Faculty of Nuclear Sciences and Physical Engineering , Czech Technical University in Prague , Prague 11519 , Czech Republic
| | - Yves Michel
- Cis Bio International Ion Beam Applications SA , Gif sur Yvette 91192 , France
| | - Daniel Asker
- Institute of Pharmaceutical Science , King's College London , London SE1 9NH , United Kingdom
| | - Jane K Sosabowski
- Centre for Molecular Oncology, Barts Cancer Institute , Queen Mary University of London , London EC1M 6BQ , United Kingdom
| | - Martin Kalbac
- J. Heyrovsky Institute of the Physical Chemistry , Dolejskova 3 , 182 23 Prague 8, Czech Republic
| | - Tatiana Da Ros
- INSTM Unit of Trieste, Department of Chemical and Pharmaceutical Sciences , University of Trieste , Via L. Giorgieri 1 , 34127 Trieste , Italy
| | - Cécilia Ménard-Moyon
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry , University of Strasbourg , UPR 3572, 67000 Strasbourg , France
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry , University of Strasbourg , UPR 3572, 67000 Strasbourg , France
| | - Ioanna Kyriakou
- Medical Physics Laboratory , University of Ioannina Medical School , Ioannina 45110 , Greece
| | - Dimitris Emfietzoglou
- Medical Physics Laboratory , University of Ioannina Medical School , Ioannina 45110 , Greece
| | | | - Belén Ballesteros
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) , CSIC and the Barcelona Institute of Science and Technology , Campus UAB, 08193 Bellaterra, Barcelona , Spain
| | - Khuloud T Al-Jamal
- Institute of Pharmaceutical Science , King's College London , London SE1 9NH , United Kingdom
| | - Gerard Tobias
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC) , Campus UAB, 08193 Bellaterra, Barcelona , Spain
| |
Collapse
|
3
|
Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnology 2019; 17:90. [PMID: 31434562 PMCID: PMC6704557 DOI: 10.1186/s12951-019-0524-9] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Accepted: 08/14/2019] [Indexed: 02/06/2023] Open
Abstract
Radiopharmaceuticals have proven to be effective agents, since they can be successfully applied for both diagnostics and therapy. Effective application of relevant radionuclides in pre-clinical and clinical studies depends on the choice of a sufficient delivery platform. Herein, we provide a comprehensive review on the most relevant aspects in radionuclide delivery using the most employed carrier systems, including, (i) monoclonal antibodies and their fragments, (ii) organic and (iii) inorganic nanoparticles, and (iv) microspheres. This review offers an extensive analysis of radionuclide delivery systems, the approaches of their modification and radiolabeling strategies with the further prospects of their implementation in multimodal imaging and disease curing. Finally, the comparative outlook on the carriers and radionuclide choice, as well as on the targeting efficiency of the developed systems is discussed.
Collapse
Affiliation(s)
- Oleksii O Peltek
- Russian Research Center of Radiology and Surgical Technologies (RRCRST) of Ministry of Public Health, Leningradskaya Street 70 Pesochny, Saint-Petersburg, 197758, Russian Federation
| | - Albert R Muslimov
- Russian Research Center of Radiology and Surgical Technologies (RRCRST) of Ministry of Public Health, Leningradskaya Street 70 Pesochny, Saint-Petersburg, 197758, Russian Federation
| | - Mikhail V Zyuzin
- Faculty of Physics and Engineering, ITMO University, St. Petersburg, 197101, Russia
| | - Alexander S Timin
- Russian Research Center of Radiology and Surgical Technologies (RRCRST) of Ministry of Public Health, Leningradskaya Street 70 Pesochny, Saint-Petersburg, 197758, Russian Federation.
- Research School of Chemical and Biomedical Engineering, National Research Tomsk Polytechnic University, Lenin Avenue 30, Tomsk, 634050, Russia.
| |
Collapse
|
4
|
Abstract
Theranostic approaches using nanotechnology have been a hot research area for the past decade. All nano drug delivery techniques and architectures have some limitations, as do diagnostic nano-approaches. Thus, combining nano drug delivery strategies with diagnostic techniques using nanoparticles for improving imaging modalities has been the key to fill up those gaps. In the past decade, lots of approaches have been made with different combinations of biomaterials fabricated/synthesized to nanostructures with modified surface functionalization to improve their overall theranostic properties. This article summarizes recent research works based on the biomaterials used for fabricating these nanostructures. Their combinations with other biomaterials have been demonstrated with their overall advantages and limitations.
Collapse
|
5
|
Joshi K, Mazumder B, Chattopadhyay P, Bora NS, Goyary D, Karmakar S. Graphene Family of Nanomaterials: Reviewing Advanced Applications in Drug delivery and Medicine. Curr Drug Deliv 2019; 16:195-214. [DOI: 10.2174/1567201815666181031162208] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Revised: 10/16/2018] [Accepted: 10/24/2018] [Indexed: 12/12/2022]
Abstract
Graphene in nano form has proven to be one of the most remarkable materials. It has a single
atom thick molecular structure and it possesses exceptional physical strength, electrical and electronic
properties. Applications of the Graphene Family of Nanomaterials (GFNs) in different fields of therapy
have emerged, including for targeted drug delivery in cancer, gene delivery, antimicrobial therapy, tissue
engineering and more recently in more diseases including HIV. This review seeks to analyze current
advances of potential applications of graphene and its family of nano-materials for drug delivery and
other major biomedical purposes. Moreover, safety and toxicity are the major roadblocks preventing the
use of GFNs in therapeutics. This review intends to analyze the safety and biocompatibility of GFNs
along with the discussion on the latest techniques developed for toxicity reduction and biocompatibility
enhancement of GFNs. This review seeks to evaluate how GFNs in future will serve as biocompatible
and useful biomaterials in therapeutics.
Collapse
Affiliation(s)
| | - Bhaskar Mazumder
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, India
| | | | | | | | | |
Collapse
|
6
|
Ficociello G, De Caris MG, Trillò G, Cavallini D, Sarto MS, Uccelletti D, Mancini P. Anti-Candidal Activity and In Vitro Cytotoxicity Assessment of Graphene Nanoplatelets Decorated with Zinc Oxide Nanorods. NANOMATERIALS (BASEL, SWITZERLAND) 2018; 8:E752. [PMID: 30248950 PMCID: PMC6215111 DOI: 10.3390/nano8100752] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Revised: 09/12/2018] [Accepted: 09/19/2018] [Indexed: 12/14/2022]
Abstract
Candida albicans is the most common pathogenic fungus that is isolated in nosocomial infections in medically and immune-compromised patients. The ability of C. albicans to convert its form from yeast to hyphal morphology contributes to biofilm development that effectively shelters Candida against the action of antifungals molecules. In the last years, nanocomposites are the most promising solutions against drug-resistant microorganisms. The aim of this study was to investigate the antifungal activity of graphene nanoplateles decorated with zinc oxide nanorods (ZNGs) against the human pathogen Candida albicans. We observed that ZNGs were able to induce a significant mortality in fungal cells, as well as to affect the main virulence factors of this fungus or rather the hyphal development and biofilm formation. Reactive Oxygen Species (ROS) formation in yeast cells resulted one of the mechanisms of ZNGs to induce mortality. Finally, the toxicity of this nanomaterial was tested also on human keratinocyte cell line HaCaT. Our data indicated that ZNGs resulted not toxic when their aggregation state decreased by adding glycerol as emulsifier to ZNGs suspensions or when HaCaT cells were grown on ZNGs-coated glasses. Overall, the results that were obtained indicated that ZNGs could be exploited as an antifungal nanomaterial with a high degree of biocompatibility on human cells.
Collapse
Affiliation(s)
- Graziella Ficociello
- Department of Biology and Biotechnology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
| | - Maria Giovanna De Caris
- Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
| | - Giusy Trillò
- Department of Biology and Biotechnology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
| | - Domenico Cavallini
- Department of Aerospace, Electrical and Energy Engineering, Sapienza University of Rome, Via Eudossiana 18, 00184 Rome, Italy.
- Research Center for Nanotechnology Applied to Engineering of Sapienza University (CNIS), Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
- Sapienza Nanotechnology & Nano-science Laboratory (SNN Lab), Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
| | - Maria Sabrina Sarto
- Department of Aerospace, Electrical and Energy Engineering, Sapienza University of Rome, Via Eudossiana 18, 00184 Rome, Italy.
- Research Center for Nanotechnology Applied to Engineering of Sapienza University (CNIS), Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
- Sapienza Nanotechnology & Nano-science Laboratory (SNN Lab), Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
| | - Daniela Uccelletti
- Department of Biology and Biotechnology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
- Sapienza Nanotechnology & Nano-science Laboratory (SNN Lab), Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
| | - Patrizia Mancini
- Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
| |
Collapse
|
7
|
Kim J, Narayan RJ, Lu X, Jay M. Neutron-activatable needles for radionuclide therapy of solid tumors. J Biomed Mater Res A 2017; 105:3273-3280. [DOI: 10.1002/jbm.a.36185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Revised: 08/02/2017] [Accepted: 08/07/2017] [Indexed: 11/05/2022]
Affiliation(s)
- Junghyun Kim
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy; University of North Carolina; Chapel Hill North Carolina 27599
| | - Roger J. Narayan
- Joint Department of Biomedical Engineering; University of North Carolina and North Carolina State University; Raleigh North Carolina 27599
| | - Xiuling Lu
- Department of Pharmaceutical Sciences; University of Connecticut; Storrs Connecticut 06269
| | - Michael Jay
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy; University of North Carolina; Chapel Hill North Carolina 27599
| |
Collapse
|